Dr. Mehta-Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4921 Parkview Pl
Saint Louis, MO 63110Phone+1 314-747-7222Fax+1 314-362-3192- Is this information wrong?
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2010 - 2012
Northwestern University The Feinberg School of MedicineClass of 2009
Certifications & Licensure
IL State Medical License 2020 - 2026
MO State Medical License 2016 - 2025
NY State Medical License 2011 - 2018- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Minimal Residual Disease in Peripheral T-cell Lymphoma Start of enrollment: 2017 Jul 31
- Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma Start of enrollment: 2021 Jul 30
Roles: Principal Investigator, Contact, Study Chair
- Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma Start of enrollment: 2021 Apr 29
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsAlopecia areata after mogamulizumab treatmentNeel S. Raval, Nora A. Alexander, Karlee De Monnin, Christine C. Yokoyama, Neha Mehta-Shah, Ilana S. Rosman, Amy Musiek> ;JAAD Case Reports. 2021 Nov 1
- An Update on the Current Genomic Landscape of Breast Implant-Associated Anaplastic Large Cell Lymphoma.Sean Harrop, Neha Mehta-Shah, Criselle D'Souza, Ella R. Thompson, Anand K. Deva, Henry Miles Prince> ;Cancers. 2021 Sep 30
- 15 citationsRomidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohortsNeha Mehta-Shah, Matthew A. Lunning, Alison J. Moskowitz, Adam M. Boruchov, Jia Ruan, Peggy Lynch, Paul A. Hamlin, John P. Leonard, Matthew J. Matasar, Patricia L. Mys...> ;American Journal of Hematology. 2021 Jul 12
- Join now to see all
Abstracts/Posters
- Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malig...Neha Mehta-Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Dose Optimization of Duvelisib in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial: Selection of Regimen for the Dose-Expan...Neha Mehta-Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Aggressive Non-Hodgkin Lymphomas: It's Getting Personal61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Rituximab/Bendamustine and Rituximab/Cytarabine (RB/RC) Induction Chemotherapy for Transplant-Eligible Patients with Mantle Cell Lymphoma: A Pooled Analysis of Two Pha...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Black Patients with CLL Face Shorter Overall SurvivalJune 5th, 2022- What Is the Optimal Frontline Treatment for PTCL?June 23rd, 2021
Hospital Affiliations
Barnes-Jewish HospitalSaint Louis, Missouri
Siteman Cancer CenterSaint Louis, Missouri- Barnes-Jewish West County HospitalSaint Louis, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
